Showing 31-40 of 3039 results for "".
Breaking News From the ESCRS Congress in Copenhagen
https://modernod.com/podcasts/eyewire-news-the-podcast/breaking-news-from-the-escrs-congress-in-copenhagen/39871/EyewireTV reports on new products and breaking news live from the ESCRS Congress in Copenhagen. Learn more about your ad choices. Visit megaphone.fm/adchoicesAECOS Presentation Summaries
https://modernod.com/podcasts/eyewire-news-the-podcast/aecos-presentation-summaries/37093/Leading ophthalmologists share summaries of their presentations live from thee AECOS Summer Symposium. Learn more about your ad choices. Visit megaphone.fm/adchoicesSpecial Report: Executives Discuss Overcoming Challenges
https://modernod.com/podcasts/eyewire-news-the-podcast/special-report-executives-discuss-overcoming-challenges/37086/Ophthalmology executives share challenging situations they encountered, as well as the steps needed to overcome the challenge. Learn more about your ad choices. Visit megaphone.fm/adchoicesLenz Therapeutics' Vizz Commerically Launched
https://modernod.com/podcasts/eyewire-news-the-podcast/lenz-therapeutics-vizz-commerically-launched/39874/A first-of-its-kind presbyopia eye drop is now commercially available; Lumibird introduces ICL Guru Integration on its ultrasound platform; and the makers of gene therapy candidates for retinal diseases provide clinical updates. Learn more about your ad choices. Visit megaphone.fm/adchoicesAlcon Acquires LumiThera
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-acquires-lumithera/37092/Alcon makes a major acquisition to bolster is vitreoretinal surgery portfolio; the European Commission (EC) approves Eylea 8 mg for extended treatment intervals; and Eric Donnenfeld, MD, discusses the business of myopia management. Learn more about your ad choices. Visit megaphone.fm/adchoicesOrasis Launches Presbyopia Eye Drop Qlosi
https://modernod.com/podcasts/eyewire-news-the-podcast/orasis-launches-presbyopia-eye-drop-qlosi/37080/A presbyopia drop is officially launched in the US; Nordic Pharma receives European approval for its novel dry eye therapy; and Tenpoint submits an NDA for a presbyopia eye drop candidate. Learn more about your ad choices. Visit megaphone.fm/adchoicesB+L Bolsters Glaucoma Offerings with Elios Acquisition
https://modernod.com/podcasts/eyewire-news-the-podcast/bl-bolsters-glaucoma-offerings-with-elios-acquisition/37063/Bausch + Lomb makes an acquisition to expand its glaucoma offerings; Roche gets a major approval in Europe for Vabysmo; and EssilorLuxottica buys a maker of noninvasive ophthalmic medical devices. Learn more about your ad choices. Visit megaphone.fm/adchoicesPhakic IOL for Presbyopia Approved in Europe
https://modernod.com/podcasts/eyewire-news-the-podcast/phakic-iol-for-presbyopia-approved-in-europe/37061/A new phakic IOL for presbyopia is approved in Europe; Nidek launches its preloaded Toric IOL Injection System internationally; and the FDA cleared a novel device for the treatment of Meibomian Gland Dysfunction. Learn more about your ad choices. Visit megaphone.fm/adchoicesSpecial Report: TFOS DEWS III Leaders Discuss New DED Guidance
https://modernod.com/podcasts/eyewire-news-the-podcast/special-report-tfos-dews-iii-leaders-discuss-new-ded-guidance/39867/Leaders from the Tear Film and Ocular Surface Society discuss the biggest takeaways from the recently released TFOS DEWS III report. Learn more about your ad choices. Visit megaphone.fm/adchoicesSpecial Report: Update on Holland Foundation
https://modernod.com/podcasts/eyewire-news-the-podcast/special-report-update-on-holland-foundation/37090/The leaders of the Holland Foundation provide an update on the progress of the foundation and its mission to restore sight for patients with Severe Ocular Surface Disease. Learn more about your ad choices. Visit megaphone.fm/adchoices